Aragen appoints Aniel Khubchandani as CEO of development and manufacturing solutions division

Ella Day | August 8, 2025 | Appointment | Manufacturing Services, Manufacturing and Production Aragen Life Sciences, CEO, Corporate, development and manufacturing solutions, manufacturing services 

Aragen Life Sciences, based in Hyderabad, India, has appointed Aniel Khubchandani as CEO of its development and manufacturing solutions (DMS) business. Khubchandani will also join the company’s management council.

Khubchandani has over 30 years of leadership experience in pharma and specialty chemicals. He previously served as CEO of Sekhmet Pharmaventures and joint-CEO at Jubilant Ingrevia Limited, with expertise spanning business transformation, strategic execution and commercial operations. He is a certified independent director and a Six Sigma Black Belt.

CEO of Aragen, Manni Kantipudi, commented: “Development and manufacturing solutions is a critical vertical with tremendous potential to significantly scale up. Aniel brings over 30 years of leadership experience to lead this journey.”

Advertisement

“I am excited to join Aragen and lead its development and manufacturing business,” said Khubchandani. “There’s an increasing focus on outsourcing, especially in the late phase and commercial manufacturing space, and the company is on the cusp of scaling to the next level of growth. I thank the board for giving me an opportunity to be a part of this exciting journey.”

Aragen operates six global sites and employs around 4,500 staff, providing research and development (R&D) and manufacturing services across the drug development pipeline.

Ella Day
8/8/25

Related Content

5997920696_ecb224068e_b

CEO of PixarBio Corporation sentenced to prison for defrauding investors

Frank Reynolds, the CEO of Boston based PixarBio Corporation, was sentenced to seven years in …

thomas-neff

FibroGen rocked by unexpected death of CEO Thomas B Neff

In a saddening turn of events, San Francisco-based FibroGen has announced that Thomas B Neff, …

allergan

Allergan shareholders reject proposal to split roles of chairman and CEO

Allergan shareholders have rejected a proposal to immediately separate the roles of CEO and chairman, …

The Gateway to Local Adoption Series

Latest content